Serial ctDNA profiling in patients with metastatic prostate cancer undergoing treatment with radium-223.

e17018Background: Assessment of the anti-tumor response to radium-223 (Ra-223) treatment is difficult in individuals. PSA levels seldom fall and imaging of existing bone metastases is imprecise. Ci...